HTA and economics in the United States: a systematic review of ICER reports to evaluate trends, identify factors associated with recommendations, and understand implications

BACKGROUND: The Institute for Clinical and Economic Review (ICER) is a prominent health technology assessment (HTA) entity in the United States that considers costs and applies economic analyses to derive price-based recommendations. ICER continues to adjust its value framework, yet discussion persi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kruzikas, Denise T, Malone, Daniel C, Pham, Sissi, Reinsch, Tyler K, Akehurst, Ron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391276/
https://www.ncbi.nlm.nih.gov/pubmed/33251996
http://dx.doi.org/10.18553/jmcp.2020.26.12.1548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391276/
https://www.ncbi.nlm.nih.gov/pubmed/33251996
http://dx.doi.org/10.18553/jmcp.2020.26.12.1548

Ejemplares similares